Research Partnership publishes new patient Living with Rheumatoid Arthritis (EU, Japan & Canada) 2019 reports
Living with Rheumatoid Arthritis (RA) is a report based on 431 patients diagnosed with RA in the 5 EU markets (France, Germany, Italy, Spain, UK), 56 patients in Japan and 112 patients in Canada. The study consists of 30-minute quantitative online and qualitative telephone interviews with patients. The qualitative interviews are enhanced with insights generated from pre-interview patient exercises – such as patient diary entries - to capture in-the-moment feelings about living with rheumatoid arthritis. These reports can be purchased as a package or individually.
The reports are intended to help pharmaceutical companies understand the attitudes and unmet needs of people with RA and how current market dynamics, with the advent of new biologics/biosimilars and oral JAK inhibitors, have affected patients’ views and behaviours towards their RA.
Head of Living With, Mariel Metcalfe commented, “An inescapable characteristic of RA is that it is unpredictable and can highly impact patients’ practical and emotional lives. While the range of RA treatments has grown, it is even more important to understand and measure how patients view these treatments and if they are truly meeting their needs.”
Living with RA is just one in a series of reports offering comprehensive insight into the chronic disease patient journey from pre-diagnosis to stabilisation. Living with Atopic Dermatitis (EU & US), Ankylosing Spondylitis & nr-AxSpA (EU & US), Psoriasis (EU), NASH (EU & US) and Diabetes LATAM are available to purchase. Psoriatic arthritis, Crohn’s, Ulcerative Colitis and Lupus are existing reports which will be updated in 2019.
Sign up to receive Rapport
Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here »